Exchange Traded Concepts’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-515
Closed -$84.4K 1729
2025
Q4
$84.4K Buy
+515
New +$80.7K ﹤0.01% 1404
2022
Q3
Sell
-2,996
Closed -$487K 1287
2022
Q2
$487K Buy
2,996
+68
+2% +$10.8K 0.01% 521
2022
Q1
$551K Buy
2,928
+616
+27% +$117K 0.01% 584
2021
Q4
$612K Buy
2,312
+42
+2% +$11.3K 0.01% 524
2021
Q3
$656K Sell
2,270
-66
-3% -$16.9K 0.02% 403
2021
Q2
$466K Buy
2,336
+146
+7% +$28.3K 0.01% 651
2021
Q1
$426K Sell
2,190
-805
-27% -$165K 0.02% 617
2020
Q4
$574K Buy
2,995
+282
+10% +$51.3K 0.03% 316
2020
Q3
$400K Buy
2,713
+236
+10% +$33.7K 0.02% 350
2020
Q2
$306K Buy
+2,477
New +$291K 0.05% 363

Other funds holding RGEN

Exchange Traded Concepts's RGEN Position: Q1 2026 in Review

Exchange Traded Concepts sold out of Repligen (RGEN) in Q1 2026, closing a stake of 515 shares — an estimated $84.4K sold.

Exchange Traded Concepts first reported a position in RGEN in Q2 2020 and held it in 10 quarters. The position peaked at $656K in Q3 2021. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Exchange Traded Concepts reported no remaining Repligen position as of Q1 2026 after selling out during the quarter.
  • Exchange Traded Concepts sold 515 Repligen shares in Q1 2026, an estimated $84.4K.
  • Exchange Traded Concepts first reported a position in Repligen in Q2 2020 and held it in 10 quarters.
  • Exchange Traded Concepts's Repligen position peaked at $656K in Q3 2021.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Exchange Traded Concepts's 13F filing for Q1 2026, filed 15 Apr 2026.